Sergio Santillana

Sergio Santillana

Founder chez Slss Consulting LLC

Fortune : - $ au 31/03/2024

61 ans
Health Technology
Consumer Services
Commercial Services

Profil

Sergio L.
Santillana
is the founder of Slss Consulting LLC.
He previously worked as the Director-Clinical Development at GSK Plc from 2012 to 2014.
From 2014 to 2016, he served as the Senior Medical Director at Takeda Pharmaceuticals International, Inc. In 2016, he held the position of Chief Medical Officer at ARIAD Pharmaceuticals, Inc. From 2017 to 2019, he worked as the Chief Medical Officer & Senior Vice President at Merrimack Pharmaceuticals, Inc. Currently, he is the Chief Medical Officer at Ikena Oncology, Inc. Dr. Santillana completed his undergraduate and doctorate degrees at Universidad Nacional Federico Villarreal.
He also holds an MBA from MIT Sloan School of Management and a graduate degree from Kellogg College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/09/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Sergio Santillana

SociétésPosteDébut
Slss Consulting LLC Founder -
Tous les postes actifs de Sergio Santillana

Anciens postes connus de Sergio Santillana

SociétésPosteFin
IKENA ONCOLOGY, INC. Chief Tech/Sci/R&D Officer 29/02/2024
MERRIMACK PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 12/04/2019
ARIAD PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/06/2017
Corporate Officer/Principal 01/03/2016
GSK PLC Corporate Officer/Principal 01/08/2014
Voir l'expérience en détail de Sergio Santillana

Formation de Sergio Santillana

Universidad Nacional Federico Villarreal Doctorate Degree
MIT Sloan School of Management Masters Business Admin
Kellogg College Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sergio Santillana

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
GSK PLC

Health Technology

MERRIMACK PHARMACEUTICALS, INC.

Health Technology

Entreprise privées4

Health Technology

Commercial Services

Ikena Oncology, Inc.

Slss Consulting LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Sergio Santillana